PP Podcast Ep 2 - Beginning Of The End Of The Drug Rep by PulsePoint published on 2020-07-22T21:27:24Z In our second episode of our podcast series “Coffee Chats,” we’re sitting down with Chris Neuner, CSO at PulsePoint, to discuss how Covid-19 has quickly changed the course for drug sales reps. Recent trends show that over 50% of doctors had already been limiting access to drug reps. With Covid-19 and related safety concerns, 52% of practitioners recently surveyed have also implemented new measures that further restrict access, so that less than 25% of physicians today are open to in-person visions by drug reps. Genre Business
